| 0 |
ALLERGY TO IMMUNOGLOBULIN THERAPY |
50 |
0.4587 |
| 1 |
INSPIRATORY CAPACITY DECREASED |
78 |
0.2816 |
| 2 |
BLOOD IMMUNOGLOBULIN G ABNORMAL |
45 |
0.2695 |
| 3 |
AMAUROSIS FUGAX |
212 |
0.1968 |
| 4 |
HUMAN ANTICHIMERIC ANTIBODY POSITIVE |
62 |
0.1845 |
| 5 |
INFUSION SITE MASS |
185 |
0.1702 |
| 6 |
INFUSION SITE DISCHARGE |
285 |
0.1624 |
| 7 |
INFUSION SITE BRUISING |
336 |
0.1554 |
| 8 |
INFUSION SITE SCAR |
65 |
0.1467 |
| 9 |
ANKLE ARTHROPLASTY |
45 |
0.1240 |
| 10 |
SHORT STATURE |
31 |
0.1183 |
| 11 |
STIFF PERSON SYNDROME |
38 |
0.1095 |
| 12 |
TRANSFUSION-RELATED CIRCULATORY OVERLOAD |
26 |
0.1074 |
| 13 |
CORONARY ARTERY ANEURYSM |
25 |
0.1064 |
| 14 |
INFUSION SITE PRURITUS |
335 |
0.1061 |
| 15 |
INFUSION SITE URTICARIA |
71 |
0.1060 |
| 16 |
COOMBS DIRECT TEST POSITIVE |
33 |
0.1058 |
| 17 |
BLOOD IMMUNOGLOBULIN G DECREASED |
262 |
0.1056 |
| 18 |
TRANSFUSION-RELATED ACUTE LUNG INJURY |
32 |
0.1039 |
| 19 |
IMMUNOGLOBULINS ABNORMAL |
27 |
0.1034 |
| 20 |
BLOOD IMMUNOGLOBULIN A DECREASED |
67 |
0.1029 |
| 21 |
INFUSION SITE HAEMORRHAGE |
327 |
0.0993 |
| 22 |
INFUSION SITE DISCOMFORT |
102 |
0.0984 |
| 23 |
IMMUNOGLOBULINS DECREASED |
130 |
0.0946 |
| 24 |
BODY HEIGHT BELOW NORMAL |
60 |
0.0933 |
| 25 |
JOINT DESTRUCTION |
145 |
0.0932 |
| 26 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
125 |
0.0869 |
| 27 |
INFUSION SITE SWELLING |
538 |
0.0854 |
| 28 |
DEVICE INFUSION ISSUE |
210 |
0.0846 |
| 29 |
INCORRECT DRUG ADMINISTRATION RATE |
359 |
0.0843 |
| 30 |
IMMUNISATION REACTION |
58 |
0.0806 |
| 31 |
BONE DENSITY INCREASED |
26 |
0.0652 |
| 32 |
BLOOD IMMUNOGLOBULIN M DECREASED |
63 |
0.0628 |
| 33 |
DEATH OF RELATIVE |
25 |
0.0616 |
| 34 |
INFUSION SITE RASH |
83 |
0.0605 |
| 35 |
INSURANCE ISSUE |
909 |
0.0594 |
| 36 |
INFUSION SITE ERYTHEMA |
501 |
0.0594 |
| 37 |
MULTIPLE ALLERGIES |
453 |
0.0577 |
| 38 |
BLOOD IMMUNOGLOBULIN G INCREASED |
70 |
0.0576 |
| 39 |
SMOOTH MUSCLE CELL NEOPLASM |
24 |
0.0574 |
| 40 |
COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
26 |
0.0566 |
| 41 |
POST-ACUTE COVID-19 SYNDROME |
69 |
0.0557 |
| 42 |
SPUTUM PURULENT |
36 |
0.0547 |
| 43 |
INFUSION SITE PAIN |
693 |
0.0537 |
| 44 |
INFUSION SITE IRRITATION |
68 |
0.0529 |
| 45 |
COVID-19 IMMUNISATION |
42 |
0.0503 |
| 46 |
INFUSION SITE DISCOLOURATION |
43 |
0.0489 |
| 47 |
MENINGITIS ASEPTIC |
218 |
0.0485 |
| 48 |
THROMBOCYTOPENIA NEONATAL |
20 |
0.0475 |
| 49 |
IMMUNOGLOBULINS INCREASED |
22 |
0.0472 |
| 50 |
ALLERGY TO PLANTS |
21 |
0.0460 |
| 51 |
EHLERS-DANLOS SYNDROME |
21 |
0.0452 |
| 52 |
ANTIBODY TEST POSITIVE |
73 |
0.0439 |
| 53 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
101 |
0.0438 |
| 54 |
URINARY TRACT DISORDER |
195 |
0.0433 |
| 55 |
MYASTHENIC SYNDROME |
33 |
0.0426 |
| 56 |
INFECTED BITE |
36 |
0.0424 |
| 57 |
ALLERGIC SINUSITIS |
36 |
0.0420 |
| 58 |
INFUSION SITE OEDEMA |
35 |
0.0419 |
| 59 |
INFUSION SITE REACTION |
124 |
0.0415 |
| 60 |
NOROVIRUS INFECTION |
58 |
0.0402 |
| 61 |
SINUSITIS BACTERIAL |
41 |
0.0389 |
| 62 |
INFUSION SITE WARMTH |
46 |
0.0375 |
| 63 |
POLYARTHRITIS |
195 |
0.0370 |
| 64 |
POOR VENOUS ACCESS |
380 |
0.0367 |
| 65 |
SEASONAL ALLERGY |
475 |
0.0335 |
| 66 |
MYASTHENIA GRAVIS CRISIS |
49 |
0.0330 |
| 67 |
ENCEPHALITIS AUTOIMMUNE |
43 |
0.0327 |
| 68 |
HAND DERMATITIS |
22 |
0.0317 |
| 69 |
INFUSION SITE EXTRAVASATION |
187 |
0.0300 |
| 70 |
INFUSION SITE NODULE |
28 |
0.0291 |
| 71 |
OBSTRUCTION |
116 |
0.0290 |
| 72 |
GASTROINTESTINAL VIRAL INFECTION |
30 |
0.0288 |
| 73 |
SECONDARY IMMUNODEFICIENCY |
35 |
0.0288 |
| 74 |
HAEMORRHAGIC STROKE |
225 |
0.0288 |
| 75 |
JUVENILE IDIOPATHIC ARTHRITIS |
70 |
0.0286 |
| 76 |
INFUSION SITE INDURATION |
42 |
0.0283 |
| 77 |
IMMUNE THROMBOCYTOPENIA |
129 |
0.0281 |
| 78 |
DRUG SPECIFIC ANTIBODY |
38 |
0.0277 |
| 79 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
73 |
0.0274 |
| 80 |
MAST CELL ACTIVATION SYNDROME |
38 |
0.0271 |
| 81 |
CROUP INFECTIOUS |
21 |
0.0266 |
| 82 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
36 |
0.0266 |
| 83 |
TRANSFUSION REACTION |
23 |
0.0262 |
| 84 |
PNEUMONIA PSEUDOMONAL |
40 |
0.0261 |
| 85 |
CEREBRAL VENOUS SINUS THROMBOSIS |
22 |
0.0260 |
| 86 |
DERMATITIS CONTACT |
294 |
0.0258 |
| 87 |
CHRONIC SINUSITIS |
93 |
0.0248 |
| 88 |
DERMATOMYOSITIS |
61 |
0.0241 |
| 89 |
DRUG TOLERANCE |
121 |
0.0239 |
| 90 |
MYASTHENIA GRAVIS |
189 |
0.0234 |
| 91 |
WHEELCHAIR USER |
104 |
0.0234 |
| 92 |
PRODUCT DISTRIBUTION ISSUE |
213 |
0.0229 |
| 93 |
IMMUNE-MEDIATED MYOSITIS |
63 |
0.0228 |
| 94 |
RESPIRATORY TRACT INFECTION VIRAL |
53 |
0.0227 |
| 95 |
OCULAR DISCOMFORT |
244 |
0.0217 |
| 96 |
GASTROENTERITIS VIRAL |
370 |
0.0205 |
| 97 |
VACCINATION FAILURE |
34 |
0.0204 |
| 98 |
RENAL TRANSPLANT FAILURE |
20 |
0.0202 |
| 99 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
26 |
0.0197 |
| 100 |
RESPIRATORY TRACT INFECTION |
513 |
0.0197 |
| 101 |
ALLERGY TO CHEMICALS |
24 |
0.0193 |
| 102 |
CYTOMEGALOVIRUS VIRAEMIA |
85 |
0.0191 |
| 103 |
BRONCHIECTASIS |
127 |
0.0188 |
| 104 |
ADRENAL INSUFFICIENCY |
228 |
0.0188 |
| 105 |
SINUSITIS |
1900 |
0.0185 |
| 106 |
VEIN RUPTURE |
31 |
0.0185 |
| 107 |
SHOULDER FRACTURE |
30 |
0.0183 |
| 108 |
EAR INFECTION |
484 |
0.0182 |
| 109 |
RHEUMATOID FACTOR POSITIVE |
104 |
0.0180 |
| 110 |
PARAINFLUENZAE VIRUS INFECTION |
27 |
0.0177 |
| 111 |
MULTIPLE-DRUG RESISTANCE |
55 |
0.0177 |
| 112 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
154 |
0.0177 |
| 113 |
HAEMOLYTIC ANAEMIA |
151 |
0.0168 |
| 114 |
GENERALISED OEDEMA |
208 |
0.0168 |
| 115 |
HAEMATOLOGICAL INFECTION |
41 |
0.0167 |
| 116 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
74 |
0.0167 |
| 117 |
DISCHARGE |
23 |
0.0166 |
| 118 |
VASCULAR DEVICE INFECTION |
75 |
0.0165 |
| 119 |
ARTHROPOD STING |
27 |
0.0162 |
| 120 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
38 |
0.0162 |
| 121 |
LYME DISEASE |
54 |
0.0162 |
| 122 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
885 |
0.0161 |
| 123 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
117 |
0.0156 |
| 124 |
COVID-19 PNEUMONIA |
183 |
0.0155 |
| 125 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
53 |
0.0154 |
| 126 |
PHARYNGITIS STREPTOCOCCAL |
164 |
0.0151 |
| 127 |
ASPERGILLUS INFECTION |
99 |
0.0151 |
| 128 |
UPPER RESPIRATORY TRACT INFECTION |
694 |
0.0150 |
| 129 |
RHINOVIRUS INFECTION |
58 |
0.0149 |
| 130 |
EPSTEIN-BARR VIRUS INFECTION |
93 |
0.0149 |
| 131 |
HEAD DISCOMFORT |
262 |
0.0148 |
| 132 |
SKIN INFECTION |
166 |
0.0148 |
| 133 |
ANIMAL BITE |
39 |
0.0146 |
| 134 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
104 |
0.0145 |
| 135 |
IMMUNODEFICIENCY |
216 |
0.0145 |
| 136 |
EYE CONTUSION |
30 |
0.0142 |
| 137 |
STREPTOCOCCAL INFECTION |
79 |
0.0142 |
| 138 |
HYPOGAMMAGLOBULINAEMIA |
93 |
0.0141 |
| 139 |
BODY TEMPERATURE ABNORMAL |
26 |
0.0141 |
| 140 |
SKIN LACERATION |
152 |
0.0140 |
| 141 |
AUTOIMMUNE DISORDER |
136 |
0.0139 |
| 142 |
GASTROINTESTINAL INFECTION |
124 |
0.0138 |
| 143 |
JC VIRUS INFECTION |
22 |
0.0138 |
| 144 |
SUSPECTED COVID-19 |
45 |
0.0136 |
| 145 |
PNEUMONIA BACTERIAL |
124 |
0.0135 |
| 146 |
TOOTH INFECTION |
177 |
0.0134 |
| 147 |
VIRAL INFECTION |
444 |
0.0133 |
| 148 |
SINUS DISORDER |
263 |
0.0133 |
| 149 |
PSEUDOMONAS INFECTION |
113 |
0.0132 |
| 150 |
GENE MUTATION |
26 |
0.0131 |
| 151 |
ADENOVIRUS INFECTION |
38 |
0.0131 |
| 152 |
FOOD POISONING |
70 |
0.0131 |
| 153 |
SALMONELLOSIS |
22 |
0.0130 |
| 154 |
HAEMOLYSIS |
99 |
0.0128 |
| 155 |
WEIGHT FLUCTUATION |
134 |
0.0128 |
| 156 |
TRANSPLANT REJECTION |
102 |
0.0127 |
| 157 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
25 |
0.0127 |
| 158 |
HYPOPROTEINAEMIA |
24 |
0.0126 |
| 159 |
INFUSION RELATED REACTION |
830 |
0.0125 |
| 160 |
ARTHROPOD BITE |
92 |
0.0124 |
| 161 |
COVID-19 |
2175 |
0.0124 |
| 162 |
LYMPHADENITIS |
30 |
0.0124 |
| 163 |
ORAL INFECTION |
48 |
0.0123 |
| 164 |
SKIN ABRASION |
58 |
0.0123 |
| 165 |
BREAST DISORDER |
25 |
0.0122 |
| 166 |
PNEUMONIA FUNGAL |
48 |
0.0122 |
| 167 |
INFECTIOUS MONONUCLEOSIS |
27 |
0.0120 |
| 168 |
ILLNESS |
1228 |
0.0119 |
| 169 |
AUTOIMMUNE THYROIDITIS |
45 |
0.0119 |
| 170 |
ANTIPHOSPHOLIPID SYNDROME |
19 |
0.0118 |
| 171 |
FINE MOTOR SKILL DYSFUNCTION |
34 |
0.0117 |
| 172 |
HYPERVOLAEMIA |
58 |
0.0117 |
| 173 |
EYE INFECTION |
130 |
0.0115 |
| 174 |
INABILITY TO AFFORD MEDICATION |
114 |
0.0115 |
| 175 |
KIDNEY INFECTION |
225 |
0.0115 |
| 176 |
ELECTRIC SHOCK SENSATION |
32 |
0.0114 |
| 177 |
PHOTOPHOBIA |
214 |
0.0114 |
| 178 |
OXYGEN SATURATION ABNORMAL |
32 |
0.0113 |
| 179 |
PARANASAL SINUS DISCOMFORT |
42 |
0.0111 |
| 180 |
ANTINUCLEAR ANTIBODY POSITIVE |
36 |
0.0111 |
| 181 |
SUSPECTED OFF LABEL USE |
50 |
0.0111 |
| 182 |
GASTRIC INFECTION |
42 |
0.0110 |
| 183 |
ALTERED STATE OF CONSCIOUSNESS |
237 |
0.0109 |
| 184 |
ADRENAL DISORDER |
21 |
0.0109 |
| 185 |
MENINGITIS |
72 |
0.0108 |
| 186 |
FOOD ALLERGY |
83 |
0.0107 |
| 187 |
GUILLAIN-BARRE SYNDROME |
52 |
0.0107 |
| 188 |
BRONCHITIS |
789 |
0.0106 |
| 189 |
FOETAL GROWTH RESTRICTION |
64 |
0.0105 |
| 190 |
FOOT OPERATION |
52 |
0.0105 |
| 191 |
OBESITY |
167 |
0.0105 |
| 192 |
LIMB MASS |
23 |
0.0105 |
| 193 |
THERAPY NON-RESPONDER |
470 |
0.0104 |
| 194 |
PNEUMONIA VIRAL |
33 |
0.0103 |
| 195 |
POST PROCEDURAL INFECTION |
84 |
0.0103 |
| 196 |
PNEUMONIA CYTOMEGALOVIRAL |
20 |
0.0103 |
| 197 |
C-REACTIVE PROTEIN ABNORMAL |
66 |
0.0103 |
| 198 |
DIPLOPIA |
267 |
0.0103 |
| 199 |
POSTOPERATIVE WOUND INFECTION |
69 |
0.0102 |
| 200 |
VEIN DISORDER |
51 |
0.0102 |
| 201 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
48 |
0.0101 |
| 202 |
ATYPICAL PNEUMONIA |
30 |
0.0100 |
| 203 |
INFUSION SITE INFECTION |
23 |
0.0099 |
| 204 |
CANDIDA INFECTION |
165 |
0.0098 |
| 205 |
LOCALISED INFECTION |
229 |
0.0095 |
| 206 |
SINUS PAIN |
22 |
0.0094 |
| 207 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
20 |
0.0094 |
| 208 |
JOINT INJURY |
198 |
0.0093 |
| 209 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
27 |
0.0092 |
| 210 |
ESCHERICHIA INFECTION |
76 |
0.0092 |
| 211 |
HAEMATEMESIS |
232 |
0.0091 |
| 212 |
TENDERNESS |
94 |
0.0090 |
| 213 |
POTENTIATING DRUG INTERACTION |
30 |
0.0089 |
| 214 |
CATHETER SITE PAIN |
23 |
0.0089 |
| 215 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1589 |
0.0088 |
| 216 |
HORDEOLUM |
38 |
0.0088 |
| 217 |
INJECTION SITE DISCHARGE |
47 |
0.0087 |
| 218 |
CUSHINGOID |
28 |
0.0087 |
| 219 |
PRESYNCOPE |
211 |
0.0087 |
| 220 |
BRAIN FOG |
136 |
0.0087 |
| 221 |
CYTOMEGALOVIRUS INFECTION |
144 |
0.0087 |
| 222 |
ABDOMINAL INFECTION |
22 |
0.0086 |
| 223 |
LIMB INJURY |
231 |
0.0085 |
| 224 |
BACTERIAL INFECTION |
158 |
0.0085 |
| 225 |
SYNOVITIS |
152 |
0.0084 |
| 226 |
PRODUCT SUPPLY ISSUE |
60 |
0.0084 |
| 227 |
LIQUID PRODUCT PHYSICAL ISSUE |
61 |
0.0084 |
| 228 |
INFECTION |
1208 |
0.0083 |
| 229 |
WALKING AID USER |
55 |
0.0083 |
| 230 |
GASTROINTESTINAL TOXICITY |
40 |
0.0083 |
| 231 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
91 |
0.0082 |
| 232 |
SINUS CONGESTION |
111 |
0.0082 |
| 233 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
78 |
0.0082 |
| 234 |
ASCITES |
240 |
0.0082 |
| 235 |
FOOT DEFORMITY |
90 |
0.0081 |
| 236 |
THROMBOTIC MICROANGIOPATHY |
79 |
0.0081 |
| 237 |
FOETAL DEATH |
42 |
0.0081 |
| 238 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
20 |
0.0081 |
| 239 |
ENTEROCOCCAL INFECTION |
39 |
0.0081 |
| 240 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
41 |
0.0080 |
| 241 |
CONCUSSION |
62 |
0.0080 |
| 242 |
HYPOCALCAEMIA |
151 |
0.0080 |
| 243 |
ENCEPHALITIS |
55 |
0.0079 |
| 244 |
RHINITIS |
64 |
0.0079 |
| 245 |
BLOOD IRON DECREASED |
94 |
0.0079 |
| 246 |
NEEDLE ISSUE |
229 |
0.0079 |
| 247 |
PARANASAL SINUS HYPERSECRETION |
30 |
0.0079 |
| 248 |
RECURRENT CANCER |
32 |
0.0078 |
| 249 |
BLOOD LACTIC ACID INCREASED |
41 |
0.0078 |
| 250 |
PULMONARY FIBROSIS |
149 |
0.0078 |
| 251 |
ARTHRITIS INFECTIVE |
36 |
0.0078 |
| 252 |
TOOTH ABSCESS |
79 |
0.0078 |
| 253 |
CREPITATIONS |
23 |
0.0077 |
| 254 |
KIDNEY TRANSPLANT REJECTION |
37 |
0.0077 |
| 255 |
BK VIRUS INFECTION |
26 |
0.0077 |
| 256 |
JOINT EFFUSION |
53 |
0.0077 |
| 257 |
PEMPHIGUS |
96 |
0.0077 |
| 258 |
NODULE |
99 |
0.0076 |
| 259 |
BLOOD PRESSURE ABNORMAL |
149 |
0.0075 |
| 260 |
BLOOD PRESSURE SYSTOLIC DECREASED |
34 |
0.0075 |
| 261 |
FUNGAL INFECTION |
249 |
0.0075 |
| 262 |
ABDOMINAL MASS |
20 |
0.0075 |
| 263 |
CYSTITIS |
237 |
0.0074 |
| 264 |
PREGNANCY |
149 |
0.0074 |
| 265 |
FOOT FRACTURE |
140 |
0.0074 |
| 266 |
CHILLS |
860 |
0.0073 |
| 267 |
ORAL FUNGAL INFECTION |
20 |
0.0073 |
| 268 |
LIGAMENT SPRAIN |
72 |
0.0073 |
| 269 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
73 |
0.0073 |
| 270 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
212 |
0.0072 |
| 271 |
PRODUCT AVAILABILITY ISSUE |
164 |
0.0072 |
| 272 |
LOWER RESPIRATORY TRACT INFECTION |
324 |
0.0071 |
| 273 |
SENSITIVE SKIN |
52 |
0.0070 |
| 274 |
SERUM FERRITIN INCREASED |
37 |
0.0070 |
| 275 |
PHARYNGITIS |
87 |
0.0070 |
| 276 |
INFLUENZA |
776 |
0.0070 |
| 277 |
PYODERMA GANGRENOSUM |
25 |
0.0069 |
| 278 |
HAND FRACTURE |
49 |
0.0069 |
| 279 |
TACHYPNOEA |
94 |
0.0069 |
| 280 |
LEUKAEMIA |
65 |
0.0069 |
| 281 |
PARTIAL SEIZURES |
36 |
0.0069 |
| 282 |
POST PROCEDURAL COMPLICATION |
132 |
0.0069 |
| 283 |
FIBROMYALGIA |
166 |
0.0068 |
| 284 |
SEPTIC SHOCK |
296 |
0.0068 |
| 285 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
241 |
0.0068 |
| 286 |
HAND DEFORMITY |
89 |
0.0068 |
| 287 |
URINARY TRACT INFECTION |
1155 |
0.0068 |
| 288 |
RESPIRATORY RATE INCREASED |
60 |
0.0068 |
| 289 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
32 |
0.0067 |
| 290 |
KLEBSIELLA INFECTION |
34 |
0.0067 |
| 291 |
HAEMATURIA |
226 |
0.0066 |
| 292 |
PRODUCT LEAKAGE |
37 |
0.0066 |
| 293 |
UPPER-AIRWAY COUGH SYNDROME |
54 |
0.0065 |
| 294 |
MASTICATION DISORDER |
20 |
0.0065 |
| 295 |
SCAR |
111 |
0.0065 |
| 296 |
THERAPY PARTIAL RESPONDER |
101 |
0.0065 |
| 297 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
183 |
0.0065 |
| 298 |
STAPHYLOCOCCAL BACTERAEMIA |
28 |
0.0064 |
| 299 |
FUNGAL SKIN INFECTION |
26 |
0.0064 |
| 300 |
MUSCULOSKELETAL DISCOMFORT |
110 |
0.0064 |
| 301 |
PRODUCT DOSE OMISSION ISSUE |
1870 |
0.0064 |
| 302 |
MUSCLE STRAIN |
55 |
0.0064 |
| 303 |
CLOSTRIDIUM DIFFICILE INFECTION |
138 |
0.0063 |
| 304 |
FEAR OF INJECTION |
45 |
0.0063 |
| 305 |
SPLENOMEGALY |
72 |
0.0061 |
| 306 |
BACTERIAL SEPSIS |
20 |
0.0061 |
| 307 |
EAR DISORDER |
28 |
0.0061 |
| 308 |
BLINDNESS |
249 |
0.0061 |
| 309 |
ABSCESS LIMB |
26 |
0.0061 |
| 310 |
STAPHYLOCOCCAL INFECTION |
201 |
0.0061 |
| 311 |
SEPSIS |
677 |
0.0061 |
| 312 |
FACE INJURY |
23 |
0.0061 |
| 313 |
SKIN INJURY |
20 |
0.0060 |
| 314 |
NASOPHARYNGITIS |
1109 |
0.0060 |
| 315 |
PLATELET COUNT ABNORMAL |
36 |
0.0059 |
| 316 |
BLOOD PRESSURE INCREASED |
909 |
0.0059 |
| 317 |
PNEUMONIA |
1924 |
0.0059 |
| 318 |
ARTHRITIS |
466 |
0.0059 |
| 319 |
LIMB DISCOMFORT |
183 |
0.0059 |
| 320 |
BLOOD MAGNESIUM DECREASED |
51 |
0.0059 |
| 321 |
BODY TEMPERATURE INCREASED |
119 |
0.0058 |
| 322 |
EYELID PTOSIS |
59 |
0.0058 |
| 323 |
LYMPHOMA |
89 |
0.0058 |
| 324 |
WOUND INFECTION |
63 |
0.0057 |
| 325 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
123 |
0.0057 |
| 326 |
BRONCHOPULMONARY ASPERGILLOSIS |
44 |
0.0057 |
| 327 |
TACHYCARDIA |
504 |
0.0057 |
| 328 |
PRODUCTIVE COUGH |
270 |
0.0057 |
| 329 |
COMA |
269 |
0.0056 |
| 330 |
PERIPHERAL VENOUS DISEASE |
23 |
0.0056 |
| 331 |
TUMOUR MARKER INCREASED |
27 |
0.0056 |
| 332 |
VULVOVAGINAL PAIN |
27 |
0.0056 |
| 333 |
PULMONARY THROMBOSIS |
61 |
0.0056 |
| 334 |
HYPOALBUMINAEMIA |
43 |
0.0055 |
| 335 |
MENISCUS INJURY |
34 |
0.0055 |
| 336 |
BODY HEIGHT DECREASED |
59 |
0.0055 |
| 337 |
PULMONARY TOXICITY |
39 |
0.0055 |
| 338 |
OBSTRUCTIVE AIRWAYS DISORDER |
61 |
0.0055 |
| 339 |
THYROID MASS |
21 |
0.0055 |
| 340 |
CYTOPENIA |
67 |
0.0055 |
| 341 |
MYOSITIS |
49 |
0.0055 |
| 342 |
CELLULITIS |
274 |
0.0054 |
| 343 |
DIVERTICULITIS |
150 |
0.0054 |
| 344 |
MIGRAINE |
515 |
0.0054 |
| 345 |
HEART RATE ABNORMAL |
30 |
0.0054 |
| 346 |
HELICOBACTER INFECTION |
55 |
0.0053 |
| 347 |
BACK INJURY |
58 |
0.0053 |
| 348 |
HYPERTRANSAMINASAEMIA |
37 |
0.0053 |
| 349 |
CARDIO-RESPIRATORY ARREST |
221 |
0.0053 |
| 350 |
TINNITUS |
240 |
0.0052 |
| 351 |
SINUS HEADACHE |
31 |
0.0052 |
| 352 |
BACK DISORDER |
84 |
0.0052 |
| 353 |
CARDIAC FAILURE CHRONIC |
22 |
0.0052 |
| 354 |
RESPIRATORY TRACT CONGESTION |
82 |
0.0052 |
| 355 |
OFF LABEL USE |
4507 |
0.0051 |
| 356 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
230 |
0.0051 |
| 357 |
ARTHRITIS BACTERIAL |
21 |
0.0051 |
| 358 |
FULL BLOOD COUNT ABNORMAL |
54 |
0.0051 |
| 359 |
OROPHARYNGEAL DISCOMFORT |
46 |
0.0051 |
| 360 |
OESOPHAGEAL CANDIDIASIS |
20 |
0.0050 |
| 361 |
PARONYCHIA |
22 |
0.0050 |
| 362 |
EYE PAIN |
282 |
0.0050 |
| 363 |
HEPATITIS B |
30 |
0.0050 |
| 364 |
CONJUNCTIVITIS |
92 |
0.0050 |
| 365 |
RIB FRACTURE |
102 |
0.0050 |
| 366 |
CONTRAINDICATED PRODUCT ADMINISTERED |
150 |
0.0049 |
| 367 |
EAR PAIN |
96 |
0.0049 |
| 368 |
IMPAIRED GASTRIC EMPTYING |
67 |
0.0049 |
| 369 |
POLYP |
32 |
0.0049 |
| 370 |
NERVE COMPRESSION |
45 |
0.0049 |
| 371 |
HYPOKALAEMIA |
225 |
0.0049 |
| 372 |
PAPILLOEDEMA |
22 |
0.0049 |
| 373 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
40 |
0.0048 |
| 374 |
WRIST FRACTURE |
58 |
0.0048 |
| 375 |
MONOPLEGIA |
21 |
0.0048 |
| 376 |
GINGIVITIS |
26 |
0.0048 |
| 377 |
GASTROINTESTINAL DISORDER |
430 |
0.0048 |
| 378 |
HYPOXIA |
168 |
0.0048 |
| 379 |
UROSEPSIS |
44 |
0.0048 |
| 380 |
PULMONARY MASS |
71 |
0.0048 |
| 381 |
BREAST MASS |
32 |
0.0048 |
| 382 |
SYNOVIAL CYST |
22 |
0.0048 |
| 383 |
ROTATOR CUFF SYNDROME |
61 |
0.0047 |
| 384 |
BLOOD PRESSURE DIASTOLIC DECREASED |
35 |
0.0047 |
| 385 |
MASS |
66 |
0.0047 |
| 386 |
ARTHROPATHY |
262 |
0.0047 |
| 387 |
OSTEOMYELITIS |
85 |
0.0047 |
| 388 |
COMPRESSION FRACTURE |
25 |
0.0047 |
| 389 |
BACTERAEMIA |
55 |
0.0046 |
| 390 |
ORAL CANDIDIASIS |
61 |
0.0046 |
| 391 |
SARCOIDOSIS |
22 |
0.0046 |
| 392 |
ASTHMA |
523 |
0.0046 |
| 393 |
CATARACT |
275 |
0.0046 |
| 394 |
HERPES ZOSTER |
265 |
0.0046 |
| 395 |
THYROID DISORDER |
71 |
0.0046 |
| 396 |
LYMPHADENOPATHY |
163 |
0.0046 |
| 397 |
HERNIA |
89 |
0.0046 |
| 398 |
LUMBAR VERTEBRAL FRACTURE |
21 |
0.0046 |
| 399 |
PRODUCT USE ISSUE |
857 |
0.0046 |
| 400 |
PLEURISY |
27 |
0.0045 |
| 401 |
IMMUNOSUPPRESSION |
40 |
0.0045 |
| 402 |
CONTUSION |
436 |
0.0045 |
| 403 |
SCIATICA |
72 |
0.0045 |
| 404 |
NEPHROLITHIASIS |
207 |
0.0045 |
| 405 |
THERMAL BURN |
32 |
0.0045 |
| 406 |
ENDOCARDITIS |
23 |
0.0045 |
| 407 |
LUNG DISORDER |
219 |
0.0045 |
| 408 |
MALABSORPTION |
23 |
0.0044 |
| 409 |
PYREXIA |
1514 |
0.0044 |
| 410 |
SENSITIVITY TO WEATHER CHANGE |
23 |
0.0044 |
| 411 |
PELVIC FRACTURE |
34 |
0.0044 |
| 412 |
AUTISM SPECTRUM DISORDER |
24 |
0.0044 |
| 413 |
BLADDER DISORDER |
43 |
0.0043 |
| 414 |
GRAFT VERSUS HOST DISEASE |
31 |
0.0043 |
| 415 |
BURSITIS |
52 |
0.0043 |
| 416 |
REBOUND EFFECT |
48 |
0.0042 |
| 417 |
SPINAL DISORDER |
40 |
0.0042 |
| 418 |
ATAXIA |
50 |
0.0042 |
| 419 |
FRUSTRATION TOLERANCE DECREASED |
34 |
0.0042 |
| 420 |
BLOOD TEST ABNORMAL |
59 |
0.0042 |
| 421 |
HYPOPHOSPHATAEMIA |
31 |
0.0042 |
| 422 |
LYMPHOEDEMA |
29 |
0.0042 |
| 423 |
SPINAL FRACTURE |
84 |
0.0042 |
| 424 |
CYST |
52 |
0.0042 |
| 425 |
PRODUCT USE COMPLAINT |
66 |
0.0042 |
| 426 |
TOXIC EPIDERMAL NECROLYSIS |
63 |
0.0041 |
| 427 |
COAGULOPATHY |
69 |
0.0041 |
| 428 |
OROPHARYNGEAL PAIN |
383 |
0.0041 |
| 429 |
FALL |
1375 |
0.0041 |
| 430 |
INTRACRANIAL PRESSURE INCREASED |
23 |
0.0041 |
| 431 |
HEAD INJURY |
130 |
0.0041 |
| 432 |
INTENTIONAL PRODUCT USE ISSUE |
359 |
0.0041 |
| 433 |
PHARYNGEAL SWELLING |
40 |
0.0041 |
| 434 |
OXYGEN SATURATION DECREASED |
229 |
0.0041 |
| 435 |
GLOSSODYNIA |
91 |
0.0041 |
| 436 |
NORMAL NEWBORN |
22 |
0.0040 |
| 437 |
CYTOKINE RELEASE SYNDROME |
81 |
0.0040 |
| 438 |
NEURALGIA |
98 |
0.0040 |
| 439 |
BLOOD PRESSURE DECREASED |
267 |
0.0040 |
| 440 |
HERPES SIMPLEX |
26 |
0.0040 |
| 441 |
UPPER LIMB FRACTURE |
79 |
0.0040 |
| 442 |
FLANK PAIN |
37 |
0.0039 |
| 443 |
TREATMENT FAILURE |
327 |
0.0039 |
| 444 |
DRY THROAT |
40 |
0.0039 |
| 445 |
FACIAL PAIN |
35 |
0.0039 |
| 446 |
LOWER LIMB FRACTURE |
75 |
0.0039 |
| 447 |
SKIN CANCER |
84 |
0.0039 |
| 448 |
ROAD TRAFFIC ACCIDENT |
163 |
0.0039 |
| 449 |
NEOPLASM MALIGNANT |
260 |
0.0039 |
| 450 |
DRUG INTOLERANCE |
376 |
0.0039 |
| 451 |
SNEEZING |
87 |
0.0039 |
| 452 |
COUGH |
1087 |
0.0039 |
| 453 |
PROCEDURAL PAIN |
107 |
0.0039 |
| 454 |
FAECES SOFT |
28 |
0.0038 |
| 455 |
RESPIRATORY DISORDER |
115 |
0.0038 |
| 456 |
PNEUMONIA ASPIRATION |
96 |
0.0038 |
| 457 |
ANAPHYLACTIC REACTION |
212 |
0.0038 |
| 458 |
PETECHIAE |
40 |
0.0038 |
| 459 |
PREMATURE DELIVERY |
61 |
0.0038 |
| 460 |
LOW BIRTH WEIGHT BABY |
30 |
0.0038 |
| 461 |
C-REACTIVE PROTEIN INCREASED |
137 |
0.0038 |
| 462 |
SKIN MASS |
25 |
0.0037 |
| 463 |
LEFT VENTRICULAR DYSFUNCTION |
25 |
0.0037 |
| 464 |
ENERGY INCREASED |
22 |
0.0037 |
| 465 |
QUALITY OF LIFE DECREASED |
50 |
0.0037 |
| 466 |
PREMATURE BABY |
112 |
0.0037 |
| 467 |
STATUS EPILEPTICUS |
42 |
0.0037 |
| 468 |
WHEEZING |
219 |
0.0037 |
| 469 |
HEADACHE |
2311 |
0.0037 |
| 470 |
PARAESTHESIA ORAL |
53 |
0.0037 |
| 471 |
DECREASED IMMUNE RESPONSIVENESS |
36 |
0.0037 |
| 472 |
FOETAL EXPOSURE DURING PREGNANCY |
298 |
0.0037 |
| 473 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
259 |
0.0036 |
| 474 |
IRRITABLE BOWEL SYNDROME |
78 |
0.0036 |
| 475 |
OEDEMA |
197 |
0.0036 |
| 476 |
TOOTH FRACTURE |
40 |
0.0036 |
| 477 |
POOR QUALITY SLEEP |
78 |
0.0036 |
| 478 |
HYPERTRIGLYCERIDAEMIA |
21 |
0.0036 |
| 479 |
INTERMENSTRUAL BLEEDING |
20 |
0.0036 |
| 480 |
GASTRIC ULCER |
68 |
0.0036 |
| 481 |
OSTEOPOROSIS |
147 |
0.0036 |
| 482 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
186 |
0.0036 |
| 483 |
SCOLIOSIS |
22 |
0.0035 |
| 484 |
GINGIVAL PAIN |
28 |
0.0035 |
| 485 |
HIP FRACTURE |
113 |
0.0035 |
| 486 |
MALAISE |
1535 |
0.0035 |
| 487 |
INTERVERTEBRAL DISC DEGENERATION |
32 |
0.0035 |
| 488 |
RESPIRATORY FAILURE |
252 |
0.0035 |
| 489 |
NECK PAIN |
193 |
0.0034 |
| 490 |
MATERNAL EXPOSURE DURING PREGNANCY |
307 |
0.0034 |
| 491 |
HEPATOTOXICITY |
76 |
0.0034 |
| 492 |
DEVICE OCCLUSION |
48 |
0.0034 |
| 493 |
HYPERAESTHESIA |
28 |
0.0034 |
| 494 |
PLEURAL EFFUSION |
207 |
0.0034 |
| 495 |
LYMPHOCYTE COUNT DECREASED |
60 |
0.0034 |
| 496 |
GLUCOSE TOLERANCE IMPAIRED |
20 |
0.0034 |
| 497 |
COMPLICATION ASSOCIATED WITH DEVICE |
49 |
0.0034 |
| 498 |
CARPAL TUNNEL SYNDROME |
47 |
0.0034 |
| 499 |
NICOTINE DEPENDENCE |
26 |
0.0033 |
| 500 |
BLOOD SODIUM DECREASED |
63 |
0.0033 |
| 501 |
SYMPTOM RECURRENCE |
20 |
0.0033 |
| 502 |
NASAL CONGESTION |
195 |
0.0033 |
| 503 |
JOINT DISLOCATION |
35 |
0.0033 |
| 504 |
ASPIRATION |
36 |
0.0033 |
| 505 |
ULCER |
52 |
0.0033 |
| 506 |
BODY TEMPERATURE DECREASED |
32 |
0.0032 |
| 507 |
CEREBRAL DISORDER |
24 |
0.0032 |
| 508 |
PYELONEPHRITIS |
28 |
0.0032 |
| 509 |
FATIGUE |
2502 |
0.0032 |
| 510 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
154 |
0.0032 |
| 511 |
WEIGHT DECREASED |
891 |
0.0032 |
| 512 |
GASTROINTESTINAL INFLAMMATION |
25 |
0.0032 |
| 513 |
LYMPHOPENIA |
45 |
0.0032 |
| 514 |
VASCULITIS |
37 |
0.0032 |
| 515 |
SWELLING |
297 |
0.0032 |
| 516 |
PNEUMOTHORAX |
50 |
0.0031 |
| 517 |
APHONIA |
44 |
0.0031 |
| 518 |
THROMBOSIS |
253 |
0.0031 |
| 519 |
PRODUCT USE IN UNAPPROVED INDICATION |
779 |
0.0031 |
| 520 |
ATRIOVENTRICULAR BLOCK COMPLETE |
21 |
0.0031 |
| 521 |
ORAL HERPES |
61 |
0.0031 |
| 522 |
MUSCULAR WEAKNESS |
355 |
0.0031 |
| 523 |
ANAL INCONTINENCE |
28 |
0.0031 |
| 524 |
SYNCOPE |
311 |
0.0031 |
| 525 |
CHEST DISCOMFORT |
318 |
0.0031 |
| 526 |
ATRIOVENTRICULAR BLOCK |
24 |
0.0031 |
| 527 |
INFLUENZA LIKE ILLNESS |
255 |
0.0031 |
| 528 |
MOBILITY DECREASED |
221 |
0.0031 |
| 529 |
PRODUCT DOSE OMISSION IN ERROR |
87 |
0.0031 |
| 530 |
FEELING COLD |
85 |
0.0031 |
| 531 |
THERAPY CHANGE |
30 |
0.0030 |
| 532 |
PRODUCT PREPARATION ISSUE |
20 |
0.0030 |
| 533 |
INJECTION SITE DISCOMFORT |
32 |
0.0030 |
| 534 |
RHINORRHOEA |
195 |
0.0030 |
| 535 |
WOUND |
84 |
0.0030 |
| 536 |
PROCEDURAL COMPLICATION |
23 |
0.0030 |
| 537 |
PRODUCT PRESCRIBING ISSUE |
65 |
0.0030 |
| 538 |
ANKLE FRACTURE |
46 |
0.0030 |
| 539 |
SYRINGE ISSUE |
52 |
0.0030 |
| 540 |
IMMUNE SYSTEM DISORDER |
39 |
0.0030 |
| 541 |
DUODENAL ULCER PERFORATION |
22 |
0.0030 |
| 542 |
SPUTUM DISCOLOURED |
28 |
0.0029 |
| 543 |
BRAIN NEOPLASM |
27 |
0.0029 |
| 544 |
HIATUS HERNIA |
38 |
0.0029 |
| 545 |
ELECTROLYTE IMBALANCE |
34 |
0.0029 |
| 546 |
EXPOSURE DURING PREGNANCY |
181 |
0.0029 |
| 547 |
COLITIS |
110 |
0.0029 |
| 548 |
BACK PAIN |
674 |
0.0029 |
| 549 |
PLATELET COUNT DECREASED |
309 |
0.0029 |
| 550 |
HYPERSOMNIA |
83 |
0.0029 |
| 551 |
SLEEP APNOEA SYNDROME |
55 |
0.0029 |
| 552 |
TOOTH DISORDER |
64 |
0.0029 |
| 553 |
NEOPLASM |
33 |
0.0029 |
| 554 |
RESPIRATORY DISTRESS |
79 |
0.0029 |
| 555 |
DECUBITUS ULCER |
23 |
0.0028 |
| 556 |
PRODUCT ADMINISTRATION ERROR |
57 |
0.0028 |
| 557 |
THERAPY INTERRUPTED |
200 |
0.0028 |
| 558 |
ATELECTASIS |
27 |
0.0028 |
| 559 |
DEVICE RELATED INFECTION |
43 |
0.0028 |
| 560 |
ACUTE HEPATIC FAILURE |
38 |
0.0028 |
| 561 |
MUSCULOSKELETAL CHEST PAIN |
43 |
0.0028 |
| 562 |
EMPHYSEMA |
28 |
0.0028 |
| 563 |
SQUAMOUS CELL CARCINOMA |
26 |
0.0028 |
| 564 |
AORTIC ANEURYSM |
21 |
0.0028 |
| 565 |
ABSCESS |
44 |
0.0028 |
| 566 |
LIVE BIRTH |
23 |
0.0027 |
| 567 |
BEDRIDDEN |
36 |
0.0027 |
| 568 |
HEART RATE DECREASED |
96 |
0.0027 |
| 569 |
GRIP STRENGTH DECREASED |
24 |
0.0027 |
| 570 |
TRANSIENT ISCHAEMIC ATTACK |
92 |
0.0027 |
| 571 |
INTERSTITIAL LUNG DISEASE |
132 |
0.0027 |
| 572 |
PANCYTOPENIA |
152 |
0.0027 |
| 573 |
SECRETION DISCHARGE |
34 |
0.0027 |
| 574 |
SHOCK HAEMORRHAGIC |
22 |
0.0027 |
| 575 |
PULMONARY EMBOLISM |
256 |
0.0027 |
| 576 |
MYALGIA |
458 |
0.0027 |
| 577 |
BRAIN INJURY |
27 |
0.0027 |
| 578 |
CONDITION AGGRAVATED |
816 |
0.0027 |
| 579 |
APPENDICITIS |
25 |
0.0027 |
| 580 |
PRODUCT ADMINISTRATION INTERRUPTED |
21 |
0.0027 |
| 581 |
LOSS OF CONSCIOUSNESS |
340 |
0.0027 |
| 582 |
TOOTHACHE |
48 |
0.0026 |
| 583 |
BONE DENSITY DECREASED |
83 |
0.0026 |
| 584 |
DRUG RESISTANCE |
68 |
0.0026 |
| 585 |
ABDOMINAL PAIN |
614 |
0.0026 |
| 586 |
GAIT INABILITY |
88 |
0.0026 |
| 587 |
SKIN REACTION |
37 |
0.0026 |
| 588 |
MYOCARDITIS |
30 |
0.0026 |
| 589 |
DEEP VEIN THROMBOSIS |
170 |
0.0026 |
| 590 |
INFLAMMATION |
135 |
0.0026 |
| 591 |
NEUROPATHY PERIPHERAL |
248 |
0.0026 |
| 592 |
PRESCRIBED UNDERDOSE |
52 |
0.0026 |
| 593 |
ABDOMINAL DISTENSION |
272 |
0.0026 |
| 594 |
ACUTE RESPIRATORY FAILURE |
50 |
0.0026 |
| 595 |
RENAL DISORDER |
121 |
0.0026 |
| 596 |
ACCIDENT |
31 |
0.0026 |
| 597 |
FACIAL PARALYSIS |
22 |
0.0026 |
| 598 |
FOLLICULITIS |
27 |
0.0026 |
| 599 |
RHEUMATOID ARTHRITIS |
292 |
0.0026 |
| 600 |
ABORTION SPONTANEOUS |
103 |
0.0026 |
| 601 |
HEART RATE INCREASED |
253 |
0.0026 |
| 602 |
RENAL PAIN |
27 |
0.0025 |
| 603 |
HEPATOMEGALY |
25 |
0.0025 |
| 604 |
LEUKOPENIA |
127 |
0.0025 |
| 605 |
FURUNCLE |
20 |
0.0025 |
| 606 |
ASTHENIA |
948 |
0.0025 |
| 607 |
URINE OUTPUT DECREASED |
22 |
0.0025 |
| 608 |
HEREDITARY ANGIOEDEMA |
27 |
0.0025 |
| 609 |
BLOOD PRESSURE SYSTOLIC INCREASED |
49 |
0.0025 |
| 610 |
SOMNOLENCE |
505 |
0.0025 |
| 611 |
ATRIAL FLUTTER |
20 |
0.0025 |
| 612 |
NEPHROPATHY TOXIC |
28 |
0.0025 |
| 613 |
SPINAL PAIN |
29 |
0.0025 |
| 614 |
SLUGGISHNESS |
25 |
0.0024 |
| 615 |
COELIAC DISEASE |
24 |
0.0024 |
| 616 |
HAEMATOMA |
63 |
0.0024 |
| 617 |
MYOPATHY |
21 |
0.0024 |
| 618 |
NERVE INJURY |
27 |
0.0024 |
| 619 |
POLYNEUROPATHY |
29 |
0.0024 |
| 620 |
WEIGHT INCREASED |
542 |
0.0024 |
| 621 |
GALLBLADDER DISORDER |
43 |
0.0024 |
| 622 |
THROAT IRRITATION |
108 |
0.0024 |
| 623 |
COLD SWEAT |
42 |
0.0024 |
| 624 |
BRONCHOSPASM |
34 |
0.0024 |
| 625 |
PERICARDIAL EFFUSION |
55 |
0.0024 |
| 626 |
LUNG INFILTRATION |
21 |
0.0024 |
| 627 |
PERIPHERAL SWELLING |
366 |
0.0024 |
| 628 |
CARDIOGENIC SHOCK |
34 |
0.0024 |
| 629 |
THROMBOCYTOPENIA |
264 |
0.0024 |
| 630 |
CLOSTRIDIUM DIFFICILE COLITIS |
25 |
0.0024 |
| 631 |
SHOCK |
54 |
0.0023 |
| 632 |
GASTROOESOPHAGEAL REFLUX DISEASE |
187 |
0.0023 |
| 633 |
SKIN ULCER |
60 |
0.0023 |
| 634 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
41 |
0.0023 |
| 635 |
LUPUS-LIKE SYNDROME |
21 |
0.0023 |
| 636 |
JOINT RANGE OF MOTION DECREASED |
31 |
0.0023 |
| 637 |
CARDIOMYOPATHY |
34 |
0.0023 |
| 638 |
DRUG EFFECT LESS THAN EXPECTED |
34 |
0.0023 |
| 639 |
MUSCULOSKELETAL STIFFNESS |
201 |
0.0023 |
| 640 |
INTERVERTEBRAL DISC PROTRUSION |
50 |
0.0023 |
| 641 |
INCREASED TENDENCY TO BRUISE |
21 |
0.0023 |
| 642 |
SKIN DISORDER |
76 |
0.0023 |
| 643 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
39 |
0.0023 |
| 644 |
URTICARIA |
381 |
0.0023 |
| 645 |
HAEMORRHAGE INTRACRANIAL |
34 |
0.0023 |
| 646 |
FEEDING DISORDER |
46 |
0.0023 |
| 647 |
ARTHRALGIA |
942 |
0.0023 |
| 648 |
EPISTAXIS |
168 |
0.0022 |
| 649 |
HYPERTENSION |
471 |
0.0022 |
| 650 |
RASH PRURITIC |
120 |
0.0022 |
| 651 |
JOINT STIFFNESS |
58 |
0.0022 |
| 652 |
DYSPNOEA |
1246 |
0.0022 |
| 653 |
DIABETES MELLITUS |
167 |
0.0022 |
| 654 |
DYSPHONIA |
128 |
0.0022 |
| 655 |
SEIZURE |
252 |
0.0022 |
| 656 |
VENTRICULAR TACHYCARDIA |
36 |
0.0022 |
| 657 |
GOUT |
39 |
0.0022 |
| 658 |
VOMITING |
1019 |
0.0022 |
| 659 |
BLOOD CALCIUM INCREASED |
19 |
0.0022 |
| 660 |
BLOOD PRESSURE FLUCTUATION |
52 |
0.0022 |
| 661 |
VERTIGO |
132 |
0.0022 |
| 662 |
EATING DISORDER |
46 |
0.0022 |
| 663 |
RASH MACULAR |
75 |
0.0021 |
| 664 |
THROAT TIGHTNESS |
58 |
0.0021 |
| 665 |
RASH PAPULAR |
48 |
0.0021 |
| 666 |
BRAIN OEDEMA |
27 |
0.0021 |
| 667 |
KNEE ARTHROPLASTY |
45 |
0.0021 |
| 668 |
NEUTROPHIL COUNT DECREASED |
87 |
0.0021 |
| 669 |
DISSEMINATED INTRAVASCULAR COAGULATION |
30 |
0.0021 |
| 670 |
PAIN |
1308 |
0.0021 |
| 671 |
HEPATIC ENZYME INCREASED |
145 |
0.0021 |
| 672 |
SARS-COV-2 TEST POSITIVE |
28 |
0.0021 |
| 673 |
BASAL CELL CARCINOMA |
33 |
0.0021 |
| 674 |
NERVOUS SYSTEM DISORDER |
66 |
0.0021 |
| 675 |
SPINAL OPERATION |
26 |
0.0021 |
| 676 |
INTERNAL HAEMORRHAGE |
24 |
0.0021 |
| 677 |
AGRANULOCYTOSIS |
39 |
0.0021 |
| 678 |
VISION BLURRED |
286 |
0.0021 |
| 679 |
PLASMA CELL MYELOMA |
81 |
0.0021 |
| 680 |
PRESCRIBED OVERDOSE |
40 |
0.0021 |
| 681 |
NAUSEA |
1634 |
0.0021 |
| 682 |
BLOOD URINE PRESENT |
39 |
0.0021 |
| 683 |
CARDIAC DISORDER |
192 |
0.0021 |
| 684 |
LETHARGY |
118 |
0.0020 |
| 685 |
INJECTION SITE IRRITATION |
26 |
0.0020 |
| 686 |
HYPERSENSITIVITY |
379 |
0.0020 |
| 687 |
IMPAIRED HEALING |
67 |
0.0020 |
| 688 |
FULL BLOOD COUNT DECREASED |
41 |
0.0020 |
| 689 |
ABDOMINAL DISCOMFORT |
341 |
0.0020 |
| 690 |
SMALL INTESTINAL OBSTRUCTION |
25 |
0.0020 |
| 691 |
PAIN IN EXTREMITY |
597 |
0.0020 |
| 692 |
INJECTION SITE SWELLING |
155 |
0.0020 |
| 693 |
MALIGNANT MELANOMA |
27 |
0.0020 |
| 694 |
FEELING ABNORMAL |
479 |
0.0020 |
| 695 |
DIZZINESS |
994 |
0.0020 |
| 696 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
51 |
0.0020 |
| 697 |
WHITE BLOOD CELL COUNT INCREASED |
76 |
0.0020 |
| 698 |
SKIN LESION |
54 |
0.0020 |
| 699 |
FLUID RETENTION |
100 |
0.0020 |
| 700 |
ATRIAL FIBRILLATION |
191 |
0.0020 |
| 701 |
DYSMENORRHOEA |
26 |
0.0020 |
| 702 |
THERAPEUTIC RESPONSE SHORTENED |
65 |
0.0020 |
| 703 |
MENTAL DISORDER |
85 |
0.0020 |
| 704 |
DRUG INEFFECTIVE |
2572 |
0.0019 |
| 705 |
INJECTION SITE MASS |
72 |
0.0019 |
| 706 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
56 |
0.0019 |
| 707 |
PRURITUS |
747 |
0.0019 |
| 708 |
ABDOMINAL PAIN UPPER |
400 |
0.0019 |
| 709 |
PHOTOSENSITIVITY REACTION |
32 |
0.0019 |
| 710 |
HAEMOPTYSIS |
54 |
0.0019 |
| 711 |
ECZEMA |
101 |
0.0019 |
| 712 |
PALLOR |
52 |
0.0019 |
| 713 |
ILL-DEFINED DISORDER |
116 |
0.0019 |
| 714 |
BLISTER |
107 |
0.0019 |
| 715 |
PERICARDITIS |
32 |
0.0019 |
| 716 |
DEHYDRATION |
254 |
0.0019 |
| 717 |
GINGIVAL BLEEDING |
26 |
0.0019 |
| 718 |
DYSPHAGIA |
180 |
0.0019 |
| 719 |
MUSCLE ATROPHY |
24 |
0.0019 |
| 720 |
PERIPHERAL COLDNESS |
26 |
0.0019 |
| 721 |
DYSPNOEA EXERTIONAL |
71 |
0.0019 |
| 722 |
HEPATITIS |
48 |
0.0019 |
| 723 |
PULMONARY HYPERTENSION |
39 |
0.0019 |
| 724 |
INTESTINAL PERFORATION |
21 |
0.0019 |
| 725 |
RESTLESS LEGS SYNDROME |
34 |
0.0019 |
| 726 |
TENDON RUPTURE |
23 |
0.0019 |
| 727 |
HEPATIC CIRRHOSIS |
35 |
0.0019 |
| 728 |
MYELOSUPPRESSION |
67 |
0.0019 |
| 729 |
HAEMOGLOBIN DECREASED |
191 |
0.0019 |
| 730 |
EYE DISORDER |
61 |
0.0019 |
| 731 |
CHEST PAIN |
342 |
0.0018 |
| 732 |
SCAB |
21 |
0.0018 |
| 733 |
HYPOTENSION |
369 |
0.0018 |
| 734 |
LIVER INJURY |
45 |
0.0018 |
| 735 |
BLOOD POTASSIUM DECREASED |
55 |
0.0018 |
| 736 |
DERMATITIS ALLERGIC |
23 |
0.0018 |
| 737 |
HEPATIC STEATOSIS |
34 |
0.0018 |
| 738 |
LIVER FUNCTION TEST ABNORMAL |
53 |
0.0018 |
| 739 |
PULMONARY CONGESTION |
24 |
0.0018 |
| 740 |
COLON CANCER |
27 |
0.0018 |
| 741 |
IMPAIRED QUALITY OF LIFE |
26 |
0.0018 |
| 742 |
DRUG ERUPTION |
32 |
0.0018 |
| 743 |
LIVER DISORDER |
80 |
0.0018 |
| 744 |
POST PROCEDURAL HAEMORRHAGE |
21 |
0.0018 |
| 745 |
DIARRHOEA |
1155 |
0.0018 |
| 746 |
MALNUTRITION |
20 |
0.0018 |
| 747 |
TASTE DISORDER |
36 |
0.0018 |
| 748 |
EPILEPSY |
54 |
0.0018 |
| 749 |
GLAUCOMA |
34 |
0.0018 |
| 750 |
PSORIASIS |
230 |
0.0018 |
| 751 |
MACULAR DEGENERATION |
21 |
0.0018 |
| 752 |
WHITE BLOOD CELL COUNT DECREASED |
190 |
0.0018 |
| 753 |
PSORIATIC ARTHROPATHY |
71 |
0.0017 |
| 754 |
PARALYSIS |
25 |
0.0017 |
| 755 |
SPEECH DISORDER |
91 |
0.0017 |
| 756 |
DISEASE PROGRESSION |
205 |
0.0017 |
| 757 |
HYPOAESTHESIA ORAL |
26 |
0.0017 |
| 758 |
DEAFNESS |
45 |
0.0017 |
| 759 |
DENTAL CARIES |
19 |
0.0017 |
| 760 |
OSTEOPENIA |
26 |
0.0017 |
| 761 |
DECREASED APPETITE |
397 |
0.0017 |
| 762 |
GLOMERULAR FILTRATION RATE DECREASED |
21 |
0.0017 |
| 763 |
DYSARTHRIA |
64 |
0.0017 |
| 764 |
HIP ARTHROPLASTY |
26 |
0.0017 |
| 765 |
TENDONITIS |
26 |
0.0017 |
| 766 |
OSTEOARTHRITIS |
71 |
0.0017 |
| 767 |
MEMORY IMPAIRMENT |
229 |
0.0017 |
| 768 |
HYPOAESTHESIA |
249 |
0.0017 |
| 769 |
ERYTHEMA |
341 |
0.0017 |
| 770 |
UNDERDOSE |
121 |
0.0017 |
| 771 |
HEMIPARESIS |
28 |
0.0017 |
| 772 |
GAIT DISTURBANCE |
316 |
0.0016 |
| 773 |
MOVEMENT DISORDER |
53 |
0.0016 |
| 774 |
TREATMENT NONCOMPLIANCE |
90 |
0.0016 |
| 775 |
GASTROENTERITIS |
24 |
0.0016 |
| 776 |
CHROMATURIA |
37 |
0.0016 |
| 777 |
ANAEMIA |
312 |
0.0016 |
| 778 |
HAEMORRHAGE |
171 |
0.0016 |
| 779 |
DERMATITIS |
34 |
0.0016 |
| 780 |
DISEASE RECURRENCE |
77 |
0.0016 |
| 781 |
TREMOR |
268 |
0.0016 |
| 782 |
PLATELET COUNT INCREASED |
21 |
0.0016 |
| 783 |
DEMENTIA |
45 |
0.0016 |
| 784 |
DEPRESSED MOOD |
85 |
0.0016 |
| 785 |
INSOMNIA |
427 |
0.0016 |
| 786 |
INCORRECT DOSE ADMINISTERED |
363 |
0.0016 |
| 787 |
DISCOMFORT |
97 |
0.0016 |
| 788 |
SKIN FISSURES |
31 |
0.0016 |
| 789 |
FLUSHING |
161 |
0.0016 |
| 790 |
ORAL DISCOMFORT |
22 |
0.0016 |
| 791 |
RENAL IMPAIRMENT |
133 |
0.0016 |
| 792 |
RED BLOOD CELL COUNT DECREASED |
45 |
0.0016 |
| 793 |
GENERALISED TONIC-CLONIC SEIZURE |
26 |
0.0016 |
| 794 |
MOUTH ULCERATION |
33 |
0.0016 |
| 795 |
INTESTINAL OBSTRUCTION |
59 |
0.0016 |
| 796 |
NEUTROPENIA |
212 |
0.0016 |
| 797 |
FEBRILE NEUTROPENIA |
103 |
0.0016 |
| 798 |
GENERAL PHYSICAL HEALTH DETERIORATION |
178 |
0.0015 |
| 799 |
CIRCULATORY COLLAPSE |
26 |
0.0015 |
| 800 |
INJECTION SITE PRURITUS |
102 |
0.0015 |
| 801 |
ORAL PAIN |
34 |
0.0015 |
| 802 |
RASH |
661 |
0.0015 |
| 803 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
24 |
0.0015 |
| 804 |
ANGIOEDEMA |
67 |
0.0015 |
| 805 |
PANIC ATTACK |
55 |
0.0015 |
| 806 |
ENCEPHALOPATHY |
37 |
0.0015 |
| 807 |
BALANCE DISORDER |
129 |
0.0015 |
| 808 |
LEUKOCYTOSIS |
27 |
0.0015 |
| 809 |
APHASIA |
45 |
0.0015 |
| 810 |
CHOKING |
29 |
0.0015 |
| 811 |
PAIN IN JAW |
42 |
0.0015 |
| 812 |
GASTRITIS |
39 |
0.0015 |
| 813 |
MUSCLE TIGHTNESS |
24 |
0.0015 |
| 814 |
SWELLING FACE |
96 |
0.0015 |
| 815 |
SWOLLEN TONGUE |
46 |
0.0015 |
| 816 |
LIP SWELLING |
49 |
0.0015 |
| 817 |
CYANOSIS |
23 |
0.0015 |
| 818 |
JOINT SWELLING |
175 |
0.0014 |
| 819 |
MENTAL IMPAIRMENT |
35 |
0.0014 |
| 820 |
DELIRIUM |
50 |
0.0014 |
| 821 |
METABOLIC ACIDOSIS |
46 |
0.0014 |
| 822 |
HYPOMAGNESAEMIA |
20 |
0.0014 |
| 823 |
MUSCLE SPASMS |
263 |
0.0014 |
| 824 |
OSTEONECROSIS |
47 |
0.0014 |
| 825 |
BLINDNESS UNILATERAL |
20 |
0.0014 |
| 826 |
PARAESTHESIA |
223 |
0.0014 |
| 827 |
FEELING JITTERY |
27 |
0.0014 |
| 828 |
MUSCULOSKELETAL PAIN |
74 |
0.0014 |
| 829 |
BLOOD GLUCOSE ABNORMAL |
26 |
0.0014 |
| 830 |
CHOLELITHIASIS |
46 |
0.0014 |
| 831 |
SLEEP DISORDER |
99 |
0.0014 |
| 832 |
DRUG-INDUCED LIVER INJURY |
44 |
0.0014 |
| 833 |
HOSPITALISATION |
215 |
0.0014 |
| 834 |
NIGHT SWEATS |
45 |
0.0014 |
| 835 |
TYPE 2 DIABETES MELLITUS |
47 |
0.0014 |
| 836 |
PNEUMONITIS |
38 |
0.0014 |
| 837 |
TRANSAMINASES INCREASED |
31 |
0.0014 |
| 838 |
DEVICE ISSUE |
125 |
0.0014 |
| 839 |
COGNITIVE DISORDER |
65 |
0.0014 |
| 840 |
NO ADVERSE EVENT |
252 |
0.0014 |
| 841 |
MYELODYSPLASTIC SYNDROME |
20 |
0.0014 |
| 842 |
BRADYCARDIA |
73 |
0.0014 |
| 843 |
INJURY ASSOCIATED WITH DEVICE |
28 |
0.0014 |
| 844 |
FEELING HOT |
84 |
0.0014 |
| 845 |
PANCREATITIS |
72 |
0.0014 |
| 846 |
INJECTION SITE ERYTHEMA |
168 |
0.0014 |
| 847 |
INJECTION SITE BRUISING |
107 |
0.0013 |
| 848 |
HAEMORRHOIDS |
26 |
0.0013 |
| 849 |
RENAL FAILURE |
176 |
0.0013 |
| 850 |
DISABILITY |
26 |
0.0013 |
| 851 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
29 |
0.0013 |
| 852 |
SKIN DISCOLOURATION |
60 |
0.0013 |
| 853 |
HEPATIC FAILURE |
39 |
0.0013 |
| 854 |
EYE SWELLING |
48 |
0.0013 |
| 855 |
ANXIETY |
361 |
0.0013 |
| 856 |
ARRHYTHMIA |
60 |
0.0013 |
| 857 |
HEPATIC FUNCTION ABNORMAL |
47 |
0.0013 |
| 858 |
RASH ERYTHEMATOUS |
60 |
0.0013 |
| 859 |
PALPITATIONS |
146 |
0.0012 |
| 860 |
CARDIAC ARREST |
102 |
0.0012 |
| 861 |
ISCHAEMIC STROKE |
22 |
0.0012 |
| 862 |
CEREBRAL HAEMORRHAGE |
44 |
0.0012 |
| 863 |
JAUNDICE |
33 |
0.0012 |
| 864 |
PRODUCT PRESCRIBING ERROR |
29 |
0.0012 |
| 865 |
MULTIPLE FRACTURES |
20 |
0.0012 |
| 866 |
URINARY INCONTINENCE |
36 |
0.0012 |
| 867 |
BLOOD CREATININE INCREASED |
79 |
0.0012 |
| 868 |
DRY MOUTH |
98 |
0.0012 |
| 869 |
DEVICE BREAKAGE |
49 |
0.0012 |
| 870 |
DRUG INTERACTION |
191 |
0.0012 |
| 871 |
DEVICE LEAKAGE |
52 |
0.0012 |
| 872 |
BONE PAIN |
70 |
0.0012 |
| 873 |
VISUAL IMPAIRMENT |
146 |
0.0012 |
| 874 |
BLOOD POTASSIUM INCREASED |
19 |
0.0012 |
| 875 |
BURNING SENSATION |
82 |
0.0012 |
| 876 |
RASH MACULO-PAPULAR |
26 |
0.0012 |
| 877 |
ANAPHYLACTIC SHOCK |
30 |
0.0012 |
| 878 |
FEMUR FRACTURE |
36 |
0.0012 |
| 879 |
GASTROINTESTINAL HAEMORRHAGE |
96 |
0.0011 |
| 880 |
NERVOUSNESS |
60 |
0.0011 |
| 881 |
CARDIAC FAILURE |
92 |
0.0011 |
| 882 |
CEREBROVASCULAR ACCIDENT |
194 |
0.0011 |
| 883 |
CONSTIPATION |
249 |
0.0011 |
| 884 |
LACRIMATION INCREASED |
34 |
0.0011 |
| 885 |
HAEMATOCHEZIA |
62 |
0.0011 |
| 886 |
DEATH |
967 |
0.0011 |
| 887 |
DRY EYE |
56 |
0.0011 |
| 888 |
CARDIAC FAILURE CONGESTIVE |
90 |
0.0011 |
| 889 |
LIVER FUNCTION TEST INCREASED |
24 |
0.0011 |
| 890 |
HYPOACUSIS |
48 |
0.0011 |
| 891 |
POLLAKIURIA |
46 |
0.0011 |
| 892 |
ACUTE KIDNEY INJURY |
168 |
0.0011 |
| 893 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
37 |
0.0011 |
| 894 |
HYPERHIDROSIS |
141 |
0.0011 |
| 895 |
ASPARTATE AMINOTRANSFERASE INCREASED |
58 |
0.0011 |
| 896 |
ADVERSE DRUG REACTION |
98 |
0.0011 |
| 897 |
OEDEMA PERIPHERAL |
132 |
0.0011 |
| 898 |
ABDOMINAL PAIN LOWER |
27 |
0.0011 |
| 899 |
HEART RATE IRREGULAR |
24 |
0.0011 |
| 900 |
BONE DISORDER |
19 |
0.0010 |
| 901 |
EYE PRURITUS |
35 |
0.0010 |
| 902 |
HYPOTHYROIDISM |
33 |
0.0010 |
| 903 |
CEREBRAL INFARCTION |
25 |
0.0010 |
| 904 |
CRYING |
37 |
0.0010 |
| 905 |
INTENTIONAL DOSE OMISSION |
29 |
0.0010 |
| 906 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
25 |
0.0010 |
| 907 |
DYSPEPSIA |
98 |
0.0010 |
| 908 |
PRODUCT PHYSICAL ISSUE |
20 |
0.0010 |
| 909 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
46 |
0.0010 |
| 910 |
COLITIS ULCERATIVE |
44 |
0.0010 |
| 911 |
LABORATORY TEST ABNORMAL |
29 |
0.0010 |
| 912 |
INJECTION SITE HAEMORRHAGE |
78 |
0.0010 |
| 913 |
ALOPECIA |
189 |
0.0010 |
| 914 |
ALANINE AMINOTRANSFERASE INCREASED |
59 |
0.0010 |
| 915 |
RESTLESSNESS |
35 |
0.0010 |
| 916 |
STOMATITIS |
58 |
0.0010 |
| 917 |
MUCOSAL INFLAMMATION |
25 |
0.0010 |
| 918 |
NEOPLASM PROGRESSION |
33 |
0.0009 |
| 919 |
IRRITABILITY |
57 |
0.0009 |
| 920 |
ELECTROCARDIOGRAM QT PROLONGED |
34 |
0.0009 |
| 921 |
STEVENS-JOHNSON SYNDROME |
21 |
0.0009 |
| 922 |
CONFUSIONAL STATE |
151 |
0.0009 |
| 923 |
PULMONARY OEDEMA |
41 |
0.0009 |
| 924 |
MUSCLE TWITCHING |
21 |
0.0009 |
| 925 |
MELAENA |
20 |
0.0009 |
| 926 |
MYOCARDIAL INFARCTION |
158 |
0.0009 |
| 927 |
MENTAL STATUS CHANGES |
25 |
0.0009 |
| 928 |
DYSURIA |
33 |
0.0009 |
| 929 |
SKIN IRRITATION |
41 |
0.0009 |
| 930 |
DYSSTASIA |
26 |
0.0009 |
| 931 |
BLOOD BILIRUBIN INCREASED |
24 |
0.0009 |
| 932 |
SURGERY |
52 |
0.0009 |
| 933 |
ACUTE MYOCARDIAL INFARCTION |
26 |
0.0009 |
| 934 |
LUNG NEOPLASM MALIGNANT |
36 |
0.0009 |
| 935 |
RECTAL HAEMORRHAGE |
37 |
0.0009 |
| 936 |
BREAST CANCER |
80 |
0.0009 |
| 937 |
THERAPY CESSATION |
44 |
0.0009 |
| 938 |
PRODUCT STORAGE ERROR |
75 |
0.0009 |
| 939 |
URINARY RETENTION |
28 |
0.0008 |
| 940 |
MULTIPLE SCLEROSIS |
40 |
0.0008 |
| 941 |
DISTURBANCE IN ATTENTION |
45 |
0.0008 |
| 942 |
THERAPEUTIC RESPONSE DECREASED |
50 |
0.0008 |
| 943 |
BREAST CANCER FEMALE |
22 |
0.0008 |
| 944 |
BLOOD CHOLESTEROL INCREASED |
38 |
0.0008 |
| 945 |
OCULAR HYPERAEMIA |
38 |
0.0008 |
| 946 |
FLATULENCE |
45 |
0.0008 |
| 947 |
MEDICATION ERROR |
44 |
0.0008 |
| 948 |
AMNESIA |
51 |
0.0008 |
| 949 |
INJURY |
55 |
0.0008 |
| 950 |
DISORIENTATION |
31 |
0.0008 |
| 951 |
BLOOD GLUCOSE DECREASED |
37 |
0.0008 |
| 952 |
PSYCHOTIC DISORDER |
22 |
0.0007 |
| 953 |
DEPRESSION |
168 |
0.0007 |
| 954 |
DYSKINESIA |
30 |
0.0007 |
| 955 |
INJECTION SITE PAIN |
224 |
0.0007 |
| 956 |
GASTRIC DISORDER |
25 |
0.0007 |
| 957 |
AGITATION |
53 |
0.0007 |
| 958 |
MOOD SWINGS |
23 |
0.0007 |
| 959 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
143 |
0.0007 |
| 960 |
HOT FLUSH |
53 |
0.0007 |
| 961 |
INJECTION SITE REACTION |
48 |
0.0007 |
| 962 |
INJECTION SITE RASH |
21 |
0.0007 |
| 963 |
HYPONATRAEMIA |
38 |
0.0007 |
| 964 |
EXTRA DOSE ADMINISTERED |
26 |
0.0006 |
| 965 |
DEVICE DIFFICULT TO USE |
42 |
0.0006 |
| 966 |
DRY SKIN |
84 |
0.0006 |
| 967 |
EYE IRRITATION |
36 |
0.0006 |
| 968 |
SKIN EXFOLIATION |
52 |
0.0006 |
| 969 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
23 |
0.0006 |
| 970 |
UNEVALUABLE EVENT |
43 |
0.0006 |
| 971 |
HYPERGLYCAEMIA |
20 |
0.0005 |
| 972 |
HALLUCINATION |
41 |
0.0005 |
| 973 |
DEVICE DISLOCATION |
22 |
0.0005 |
| 974 |
THERAPEUTIC RESPONSE UNEXPECTED |
22 |
0.0005 |
| 975 |
HYPOGLYCAEMIA |
23 |
0.0005 |
| 976 |
DEVICE MALFUNCTION |
33 |
0.0005 |
| 977 |
PRODUCT SUBSTITUTION ISSUE |
26 |
0.0005 |
| 978 |
MALIGNANT NEOPLASM PROGRESSION |
46 |
0.0004 |
| 979 |
ADVERSE EVENT |
41 |
0.0004 |
| 980 |
PRODUCT QUALITY ISSUE |
58 |
0.0004 |
| 981 |
CHRONIC KIDNEY DISEASE |
32 |
0.0004 |
| 982 |
BLOOD GLUCOSE INCREASED |
75 |
0.0004 |
| 983 |
SUICIDE ATTEMPT |
22 |
0.0004 |
| 984 |
PROSTATE CANCER |
28 |
0.0003 |
| 985 |
TOXICITY TO VARIOUS AGENTS |
56 |
0.0003 |
| 986 |
DYSGEUSIA |
24 |
0.0003 |
| 987 |
ACNE |
22 |
0.0003 |
| 988 |
SUICIDAL IDEATION |
22 |
0.0002 |
| 989 |
OVERDOSE |
47 |
0.0002 |
| 990 |
EMOTIONAL DISTRESS |
26 |
0.0002 |
| 991 |
DRUG DEPENDENCE |
31 |
0.0002 |